159 related articles for article (PubMed ID: 35477274)
1. Development of Azaindole-Based Frameworks as Potential Antiviral Agents and Their Future Perspectives.
Urvashi ; Senthil Kumar JB; Das P; Tandon V
J Med Chem; 2022 May; 65(9):6454-6495. PubMed ID: 35477274
[TBL] [Abstract][Full Text] [Related]
2. Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR Pathway.
Pattabhi S; Wilkins CR; Dong R; Knoll ML; Posakony J; Kaiser S; Mire CE; Wang ML; Ireton RC; Geisbert TW; Bedard KM; Iadonato SP; Loo YM; Gale M
J Virol; 2015 Dec; 90(5):2372-87. PubMed ID: 26676770
[TBL] [Abstract][Full Text] [Related]
3. Antiviral drugs for viruses other than human immunodeficiency virus.
Razonable RR
Mayo Clin Proc; 2011 Oct; 86(10):1009-26. PubMed ID: 21964179
[TBL] [Abstract][Full Text] [Related]
4. Nitazoxanide: a first-in-class broad-spectrum antiviral agent.
Rossignol JF
Antiviral Res; 2014 Oct; 110():94-103. PubMed ID: 25108173
[TBL] [Abstract][Full Text] [Related]
5. Potential of glycyrrhizic and glycyrrhetinic acids against influenza type A and B viruses: A perspective to develop new anti-influenza compounds and drug delivery systems.
Langer D; Mlynarczyk DT; Dlugaszewska J; Tykarska E
Eur J Med Chem; 2023 Jan; 246():114934. PubMed ID: 36455358
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, cytotoxicity and antiviral evaluation of new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives.
Briguglio I; Loddo R; Laurini E; Fermeglia M; Piras S; Corona P; Giunchedi P; Gavini E; Sanna G; Giliberti G; Ibba C; Farci P; La Colla P; Pricl S; Carta A
Eur J Med Chem; 2015 Nov; 105():63-79. PubMed ID: 26479028
[TBL] [Abstract][Full Text] [Related]
7. Antiviral Activities of Pyridine Fused and Pyridine Containing Heterocycles, A Review (from 2000 to 2020).
Alizadeh SR; Ebrahimzadeh MA
Mini Rev Med Chem; 2021; 21(17):2584-2611. PubMed ID: 33573543
[TBL] [Abstract][Full Text] [Related]
8. Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.
Zannella C; Chianese A; Palomba L; Marcocci ME; Bellavita R; Merlino F; Grieco P; Folliero V; De Filippis A; Mangoni M; Nencioni L; Franci G; Galdiero M
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216177
[TBL] [Abstract][Full Text] [Related]
9. Screening methods for influenza antiviral drug discovery.
Atkins C; Evans CW; White EL; Noah JW
Expert Opin Drug Discov; 2012 May; 7(5):429-38. PubMed ID: 22435452
[TBL] [Abstract][Full Text] [Related]
10. Perspectives on antiviral drug development.
Wainberg MA
Antiviral Res; 2009 Jan; 81(1):1-5. PubMed ID: 18948140
[TBL] [Abstract][Full Text] [Related]
11. Machine Learning in Discovery of New Antivirals and Optimization of Viral Infections Therapy.
Tarasova O; Poroikov V
Curr Med Chem; 2021; 28(38):7840-7861. PubMed ID: 33949929
[TBL] [Abstract][Full Text] [Related]
12. Recent progress in designing inhibitors that target the drug-resistant M2 proton channels from the influenza A viruses.
Wang J; Li F; Ma C
Biopolymers; 2015 Jul; 104(4):291-309. PubMed ID: 25663018
[TBL] [Abstract][Full Text] [Related]
13. Evolution and Antiviral Specificities of Interferon-Induced Mx Proteins of Bats against Ebola, Influenza, and Other RNA Viruses.
Fuchs J; Hölzer M; Schilling M; Patzina C; Schoen A; Hoenen T; Zimmer G; Marz M; Weber F; Müller MA; Kochs G
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490593
[TBL] [Abstract][Full Text] [Related]
14. Antiviral role of toll-like receptor-3 agonists against seasonal and avian influenza viruses.
Wong JP; Christopher ME; Viswanathan S; Dai X; Salazar AM; Sun LQ; Wang M
Curr Pharm Des; 2009; 15(11):1269-74. PubMed ID: 19355966
[TBL] [Abstract][Full Text] [Related]
15. Antivirally active ribavirin analogues--4,5-disubstituted 1,2,3-triazole nucleosides: biological evaluation against certain respiratory viruses and computational modelling.
Krajczyk A; Kulinska K; Kulinski T; Hurst BL; Day CW; Smee DF; Ostrowski T; Januszczyk P; Zeidler J
Antivir Chem Chemother; 2014 Jan; 23(4):161-71. PubMed ID: 23538746
[TBL] [Abstract][Full Text] [Related]
16. The antiviral activity and mechanism of action of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] (HPMP) nucleosides.
Magee WC; Evans DH
Antiviral Res; 2012 Nov; 96(2):169-80. PubMed ID: 22960154
[TBL] [Abstract][Full Text] [Related]
17. Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses.
McKimm-Breschkin JL; Fry AM
Antiviral Res; 2016 May; 129():21-38. PubMed ID: 26872862
[TBL] [Abstract][Full Text] [Related]
18. Acridones as antiviral agents: synthesis, chemical and biological properties.
Sepúlveda CS; Fascio ML; García CC; D'Accorso NB; Damonte EB
Curr Med Chem; 2013; 20(19):2402-14. PubMed ID: 23521684
[TBL] [Abstract][Full Text] [Related]
19. Antiviral potential of medicinal plants against HIV, HSV, influenza, hepatitis, and coxsackievirus: A systematic review.
Akram M; Tahir IM; Shah SMA; Mahmood Z; Altaf A; Ahmad K; Munir N; Daniyal M; Nasir S; Mehboob H
Phytother Res; 2018 May; 32(5):811-822. PubMed ID: 29356205
[TBL] [Abstract][Full Text] [Related]
20. Recent progress and challenges in the discovery of new neuraminidase inhibitors.
Chamni S; De-Eknamkul W
Expert Opin Ther Pat; 2013 Apr; 23(4):409-23. PubMed ID: 23369206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
